par Salgado, Roberto;McKee, Tawnya;Lacombe, Denis;Moore, Helen;Martens, John W M;Lively, Tracy;Malik, Shakun;McDermott, Ultan;Michiels, Stefan 
;Moscow, Jeffrey J.A.;Tejpar, Sabine
Référence Nature reviews. Drug discovery, 17, 1, page (1-2)
Publication Publié, 2018-01
;Moscow, Jeffrey J.A.;Tejpar, SabineRéférence Nature reviews. Drug discovery, 17, 1, page (1-2)
Publication Publié, 2018-01
Article révisé par les pairs
| Résumé : | The availability of targeted anticancer drugs and the relative affordability of genomic analyses has led to a growing expectation among patients with cancer that they can receive personalized treatment based on the genomic signature of their tumour. Here, we discuss some of the challenges and steps needed to bring such approaches into routine practice. |
